Follow
Swati Kulkarni
Swati Kulkarni
Associate Professor of Surgery, University of Chicago
Verified email at uchicago.edu
Title
Cited by
Cited by
Year
Cyclooxygenase-2 is overexpressed in human cervical cancer
S Kulkarni, JS Rader, F Zhang, H Liapis, AT Koki, JL Masferrer, ...
Clinical Cancer Research 7 (2), 429-434, 2001
4552001
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer
CA Haiman, GK Chen, CM Vachon, F Canzian, A Dunning, RC Millikan, ...
Nature genetics 43 (12), 1210-1214, 2011
3482011
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly, RC Bhoyar, V Sardana, ...
Science 374 (6570), 995-999, 2021
3012021
Delay to formalin fixation effect on breast biomarkers
T Khoury, S Sait, H Hwang, R Chandrasekhar, G Wilding, D Tan, ...
Modern Pathology 22 (11), 1457-1467, 2009
2532009
HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic tools
DG Hicks, S Kulkarni
American journal of clinical pathology 129 (2), 263-273, 2008
2062008
Common breast cancer susceptibility loci are associated with triple-negative breast cancer
KN Stevens, CM Vachon, AM Lee, S Slager, T Lesnick, C Olswold, ...
Cancer research 71 (19), 6240-6249, 2011
1512011
The breast–thyroid cancer link: a systematic review and meta-analysis
SM Nielsen, MG White, S Hong, B Aschebrook-Kilfoy, EL Kaplan, ...
Cancer Epidemiology, Biomarkers & Prevention 25 (2), 231-238, 2016
1422016
Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study
S Yao, LE Sucheston, AE Millen, CS Johnson, DL Trump, MK Nesline, ...
PloS one 6 (2), e17251, 2011
1392011
Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009
JL Gnerlich, RT Williams, K Yao, N Jaskowiak, SA Kulkarni
Annals of surgical oncology 21, 1222-1230, 2014
1272014
Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020
N Gupta, I Praharaj, T Bhatnagar, JWV Thangaraj, S Giri, H Chauhan, ...
Indian Journal of Medical Research 151 (2-3), 236-240, 2020
932020
Postoperative adjuvant systemic therapy in completely resected non–small-cell lung cancer: a systematic review
P Bradbury, D Sivajohanathan, A Chan, S Kulkarni, Y Ung, PM Ellis
Clinical lung cancer 18 (3), 259-273. e8, 2017
912017
Trastuzumab as adjuvant therapy for early breast cancer: the importance of accurate human epidermal growth factor receptor 2 testing
DG Hicks, S Kulkarni
Archives of pathology & laboratory medicine 132 (6), 1008-1015, 2008
812008
Society of surgical oncology breast disease working group statement on prophylactic (risk-reducing) mastectomy
KK Hunt, DM Euhus, JC Boughey, AB Chagpar, SM Feldman, NM Hansen, ...
Annals of surgical oncology 24, 375-397, 2017
802017
Role of amino acids as additives on sperm motility, plasma membrane integrity and lipid peroxidation levels at pre-freeze and post-thawed ram semen
S Sangeeta, A Arangasamy, S Kulkarni, S Selvaraju
Animal reproduction science 161, 82-88, 2015
802015
Effect of delayed formalin fixation on estrogen and progesterone receptors in breast cancer: a study of three different clones
J Qiu, S Kulkarni, R Chandrasekhar, M Rees, K Hyde, G Wilding, D Tan, ...
American journal of clinical pathology 134 (5), 813-819, 2010
742010
Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status
SE McCann, S Kulkarni, M Trevisan, D Vito, J Nie, SB Edge, P Muti, ...
Breast cancer research and treatment 99, 309-311, 2006
592006
Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer
S Kulkarni, K Augoff, L Rivera, B McCue, T Khoury, A Groman, L Zhang, ...
Public Library of Science 7 (8), e42895, 2012
572012
Implementation of image processing for detection of brain tumors
SS Hunnur, A Raut, S Kulkarni
2017 International Conference on Computing Methodologies and Communication …, 2017
562017
COX-2 and PPARγ expression are potential markers of recurrence risk in mammary duct carcinoma in-situ
S Kulkarni, DB Patil, LK Diaz, EL Wiley, M Morrow, SA Khan
BMC cancer 8, 1-11, 2008
562008
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study …
J Gligorov, B Ataseven, M Verrill, M De Laurentiis, KH Jung, HA Azim, ...
European Journal of Cancer 82, 237-246, 2017
502017
The system can't perform the operation now. Try again later.
Articles 1–20